In most industries size reduction falls in two general categories: crushing and milling. Crushing typically means reducing large chanks to sizes about 0,5 to 0,75 or smaller. Milling usually means reducing mmaterial to sizes in the low-micron or even nano-size range. Milling may be done wet or dry. Attrition milling technologies relate to chemical processing applications. Media milling is one common way to achive desired results.
In most industries size reduction falls in two general categories: crushing and milling. Crushing typically means reducing large chanks to sizes about 0,5 to 0,75 or smaller. Milling usually means reducing mmaterial to sizes in the low-micron or even nano-size range. Milling may be done wet or dry. Attrition milling technologies relate to chemical processing applications. Media milling is one common way to achive desired results.
Attrition mills are more appropriate for mid-range size particles. Such millsutilize 3-10mm media to produce material ranging in size from approximately 1 to 10 microns.
MX-MAP project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed split secondment visit to project partner organization University of Padova (Italy). MX-MAP project works on development of the key strategies for MXene medical applications. 
CanbioSe Project Meeting and Project Workshop was held at European Institute of Membranes (IEM), University of Montpellier, France on September 26-27, 2023. The workshop was focused on the theme of "Commercializing Biosensors, Intellectual Property, and Knowledge Transfer from Academia to Industry.
Dr. Oleksiy Gogotsi and Veronika Zahorodna visited IEEE NAP 2023 conference held in Bratislava on September 10-15, 2023. The prime focus of the IEEE NAP-2023 was on nanoscale materials with emphasis on interdisciplinary research exploring and exploiting their unique physical and chemical proprieties for practical applications.
Director of MRC and Carbon-Ukraine Dr. Oleksiy Gogotsi visited CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA). He meet with Dr. Pierluigi Bilotto, Dr. Chriatian Pichler and their colleagues, discussing novel materials and r&d activities for new technologies.
MX-MAP Session was held during the YUCOMAT Conference 2023 titled: "Towards MXenes’ biomedical applications by high-dimensional immune MAPping", HORIZON-MSCA-2021-SE-01 project MX-MAP.
CANBIOSE project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed secondment visit to project partner organization European Institute of Membranes in Montpellier (France) on August -September 2023.
MRC researchers Dr. Oleksiy Gogotsi and Veronika Zahorodna were visiting Nanobiomedical Centre, Adam Mickewicz University in Poznan, Poland due to close collaboration with AMU team led by Dr. Igor Iatsunskiy. 
Meeting during the MXene international conference held in Drexel University on Aug. 3, 2022, and discussing the roadmap for launching MX-MAP research project on MXenes for medical applications.
Presenting our recent collaborative research paper on MXene use for PPT anticancer therapy, the biocompatibility of MXenes in vitro and in vivo studies:
